. Is there a test that utilises anti-PSA monoclonal antibodies to localise PSA-avid tumour in the body?

The issue of a persistently rising Prostatic Surface Antigen (PSA) level in blood post prostatectomy for cancer of the prostate remains problematic in clinical practice especially in patients without evidence of local recurrence or metastatic disease on MRI/PET Scan.